Breaking News
Quotes
All Instrument Types
  • All Instrument Types
  • Indices
  • Equities
  • ETFs
  • Funds
  • Commodities
  • Currencies
  • Crypto
  • Bonds
  • Certificates

Please try another search

Search website for: 
Popular News
More
Popular Analysis
More
More
Get 40% Off
/Free Sign Up
 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Aster DM Healthcare Ltd (ATRD)

Create Alert
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Create Manage my alerts 
Back
Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
 
Create New Watchlist Create
Create a new holdings portfolio Add Create
+ Add another position Close
360.00 -6.20    -1.69%
26/04 - Closed. Currency in INR ( Disclaimer )
Type:  Equity
Market:  India
ISIN:  INE914M01019 
S/N:  ASTERDM
  • Volume: 516,642
  • Bid/Ask: 359.60 / 360.00
  • Day's Range: 348.40 - 370.00
Aster DM Healthcare 360.00 -6.20 -1.69%

NS:ATRD Financials

 
A brief overview of the NS:ATRD financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Aster DM Healthcare Ltd over time.

Aster DM Healthcare Limited reported earnings results for the second quarter and six months ended September 30, 2023. For the second quarter, the company reported sales was INR 33,166.3 million compared to INR 28,163 million a year ago. Revenue was INR 33,252.2 million compared to INR 28,347.2 million a year ago. Net loss was INR 307.9 million compared to net income of INR 462.1 million a year ago. Basic loss per share from continuing operations was INR 0.62 compared to basic earnings per share from continuing operations of INR 0.93 a year ago. Diluted loss per share from continuing operations was INR 0.62 compared to diluted earnings per share from continuing operations of INR 0.93 a year ago.For the six months, sales was INR 65,320 million compared to INR 54,784.2 million a year ago. Revenue was INR 65,497.9 million compared to INR 55,341.1 million a year ago. Net loss was INR 258.9 million compared to net income of INR 1,147.5 million a year ago. Basic loss per share from continuing operations was INR 0.52 compared to basic earnings per share from continuing operations of INR 2.31 a year ago. Diluted loss per share from continuing operations was INR 0.52 compared to diluted earnings per share from continuing operations of INR 2.3 a year ago.

AnnualQuarterly  
InvestingPro Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

ATRD Income Statement

Gross margin TTM 36.4%
Operating margin TTM 7.28%
Net Profit margin TTM 2.4%
Return on Investment TTM 8.62%
 Total Revenue  Net Income
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Revenue 37106.1 33166.3 32153.7 32623.2
Gross Profit 14532.7 12132.3 11401.3 11093.4
Operating Income 3326 2044.5 1702.5 2883.4
Net Income 1792.1 -307.9 49 1707.7

ATRD Balance Sheet

Quick Ratio MRQ 0.52
Current Ratio MRQ -
LT Debt to Equity MRQ 26.83%
Total Debt to Equity MRQ 137.09%
 Total Assets  Total Liabilities
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Total Assets 157083.5 148812
Total Liabilities 108997.4 100207.4
Total Equity 48086.1 48086.1 48604.6 48604.6

ATRD Cash Flow Statement

Cash Flow/Share TTM 38.56
Revenue/Share TTM 271.53
Operating Cash Flow  -
 Cash  Net Change in Cash
Period Ending: Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities
Cash From Investing Activities
Cash From Financing Activities
Net Change in Cash
* In Millions of INR (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

I Agree

ATRD Comments

Write your thoughts about Aster DM Healthcare Ltd
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
invest market
INVEST2MARKETS Sep 14, 2023 11:14PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Delivery Buy ASTERDM above 345 Stop Loss 330 Target 360-390
Reply
0 0
Report
Right Way Trading
Right Way Trading Sep 26, 2021 4:24AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Buy is around 199-201 Target 250 Sl Close below 196 Daily Candle
Reply
1 1
Report
Ashraf Barkati
Ashraf Barkati Sep 22, 2021 9:44AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
why falling?
Reply
0 0
Report
kishor kumar Bag
kishor kumar Bag Aug 18, 2021 1:01AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Pumping and Dumping seen in #ASTERDM by operator any time carefull all investor
Reply
4 0
Report
Billy Carvalho
Billy Carvalho Aug 10, 2021 10:14AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Why is this falong today ?
Reply
0 0
Report
Shah Jaz
Shah Jaz Aug 26, 2020 10:46PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Long term investment option
Reply
2 1
Report
shiv prakash
shiv prakash Jun 20, 2020 11:26AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Aster is a big brand name in GCC Around 81pct. of its total revenue comes from GCC. Soon to expand in metro cities in India. Already have 13 hospitals in India tier 1 and 2 cities. The UAE and Oman are likely to witness growth rates of above 9pct, in anticipation of a fast-growing population. In view of the anticipated rise in the number of patients, GCC may require a collective bed capacity of 118,300 by 2022, indicating demand for 12,350 new beds. Saudi Arabia is likely to witness the largest requirement at over 7,500 new beds, followed by the UAE at more than 2,000 new beds. EBITDA and PAT to grow at a CAGR of 13%, 13% and 21% in FY19-22E, respectively. Revenues are expected to be driven by steady expansion and growth in new hospitals, clinics and pharmacies. Margins are expected to be driven by an improvement in occupancy ratios and operational efficiency in new hospitals, especially in India. Overall the stock is a bluechip available at a very low price.
Reply
5 1
Report
shiv prakash
shiv prakash Jun 20, 2020 11:22AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Bluechip Big move ahead. Easy 300 in few months. BUY
Reply
1 0
Report
saravana vel
saravana vel Oct 06, 2018 3:54PM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
company fundamentally strong.
Reply
2 0
Report
Manny Ravi
Manny Ravi Apr 16, 2018 10:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Tg 213
Reply
0 1
Report
Varun Dureja
Varun Dureja Apr 16, 2018 10:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
Hi RAVI, could you please tell me how you came to this conclusion of target?
Reply
0 0
Report
Mukesh Patel
Mukesh Patel Apr 16, 2018 10:19AM ET
Save
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Block User
How ?
Reply
0 0
Report
 
Are you sure you want to delete this chart?
Delete Cancel
 
Post
 
Replace the attached chart with a new chart ?
Replace Cancel
1000
Comment Guidelines
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Cancel Attach
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Confirm Block Cancel
Ok
Report this comment

I feel that this comment is:

Submit
Comment flagged

Thank You!

Your report has been sent to our moderators for review
Close
Continue with Google
or
Sign up with Email